Works matching IS 1082801X AND DT 2005 AND VI 40 AND IP 9

Results: 19

Medication safety and reliability: a collection of the latest drug safety news, notices, labeling changes, and drug availability issues. Advisory committee recommends continued marketing of beta2-agonists, black-box warning for formoterol.

Published in:: 2005
Publication type:: Journal Article

Letter to the editor.

Published in:

2005

By:

Tsourounis C;
Cheng C

Publication type:

Journal Article

News capsules: what's new in drug research and managed care pharmacy. Bisphosphonate maintains BMD gains achieved with parathyroid hormone.

Published in:: 2005
Publication type:: Journal Article

Cost-effectiveness of 4 empiric antimicrobial regimens in patients with community-acquired pneumonia.

Published in:

2005

By:

Frei CR;
Burgess DS

Publication type:

Journal Article

FDA drug approvals. FDA actions in brief.

Published in:: 2005
Publication type:: Journal Article

Bisphosphonate maintains BMD gains achieved with parathyroid hormone.

Published in:: Formulary, 2005, v. 40, n. 9, p. 305
Publication type:: Article

Letter to the Editor.

Published in:

2005

By:

Tsourounis, Candy;
Christine Cheng

Publication type:

Letter

Cost-effectiveness of 4 empiric antimicrobial regimens in patients with community-acquired pneumonia.

Published in:

Formulary, 2005, v. 40, n. 9, p. 298

By:

Frei, Christopher R.;
Burgess, David S.

Publication type:

Article

Focus on... muraglitazar: a dual peroxisome proliferator-activated receptor agonist.

Published in:

2005

By:

Kirwin J;
Van Amburgh J;
Quercia RA;
Coleman CI

Publication type:

Journal Article

Epilepsy and migraine.

Published in:: 2005
Publication type:: Other

Drug and Formulary Trends.

Published in:: 2005
Publication type:: Other

Selected literature.

Published in:: 2005
Publication type:: Bibliography

Advisory committee recommends continued marketing of beta<sub>2</sub>-agonists, black-box warning for formoterol.

Published in:: Formulary, 2005, v. 40, n. 9, p. 311
Publication type:: Article

Safety labeling updates & new warnings.

Published in:: Formulary, 2005, v. 40, n. 9, p. 311
Publication type:: Article

First-time generic approvals.

Published in:: Formulary, 2005, v. 40, n. 9, p. 297
Publication type:: Article

New formulations.

Published in:: Formulary, 2005, v. 40, n. 9, p. 296
Publication type:: Article

New indications.

Published in:: Formulary, 2005, v. 40, n. 9, p. 296
Publication type:: Article

Muraglitazar.

Published in:

Formulary, 2005, v. 40, n. 9, p. 285

By:

Kirwin, Jennifer;
van Amburgh, Jenny

Publication type:

Article

FDA actions in brief.

Published in:: Formulary, 2005, v. 40, n. 9, p. 296
Publication type:: Article